GB9314271D0 - Cell growth factor receptors - Google Patents

Cell growth factor receptors

Info

Publication number
GB9314271D0
GB9314271D0 GB939314271A GB9314271A GB9314271D0 GB 9314271 D0 GB9314271 D0 GB 9314271D0 GB 939314271 A GB939314271 A GB 939314271A GB 9314271 A GB9314271 A GB 9314271A GB 9314271 D0 GB9314271 D0 GB 9314271D0
Authority
GB
United Kingdom
Prior art keywords
growth factor
cell growth
factor receptors
receptors
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939314271A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Priority to GB939314271A priority Critical patent/GB9314271D0/en
Publication of GB9314271D0 publication Critical patent/GB9314271D0/en
Priority to PCT/GB1994/001480 priority patent/WO1995002187A1/en
Priority to ZA944983A priority patent/ZA944983B/en
Priority to AU70810/94A priority patent/AU7081094A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
GB939314271A 1993-07-09 1993-07-09 Cell growth factor receptors Pending GB9314271D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB939314271A GB9314271D0 (en) 1993-07-09 1993-07-09 Cell growth factor receptors
PCT/GB1994/001480 WO1995002187A1 (en) 1993-07-09 1994-07-08 Cell growth factor receptors
ZA944983A ZA944983B (en) 1993-07-09 1994-07-08 Cell growth factor receptors
AU70810/94A AU7081094A (en) 1993-07-09 1994-07-08 Cell growth factor receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314271A GB9314271D0 (en) 1993-07-09 1993-07-09 Cell growth factor receptors

Publications (1)

Publication Number Publication Date
GB9314271D0 true GB9314271D0 (en) 1993-08-18

Family

ID=10738572

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939314271A Pending GB9314271D0 (en) 1993-07-09 1993-07-09 Cell growth factor receptors

Country Status (4)

Country Link
AU (1) AU7081094A (en)
GB (1) GB9314271D0 (en)
WO (1) WO1995002187A1 (en)
ZA (1) ZA944983B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051397A (en) 1993-11-16 2000-04-18 Max Planck Gesellschaft Zur Forderung Der Wissenschaften DNA encoding MCK-10, a novel receptor tyrosine kinase
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
FR2780161B1 (en) * 1998-06-17 2000-09-29 Centre Nat Rech Scient METHOD FOR EARLY DIAGNOSIS OF CANCER BASED ON THE SEARCH FOR AUTO-ANTIBODIES DIRECTED AGAINST THE CSK PROTEIN AND KIT FOR ITS IMPLEMENTATION
PT1454992E (en) * 2003-03-07 2006-09-29 Ist Naz Stud Cura Dei Tumori KINASE-TEST OF ANAPLASTIC LYMPHOMA, REAGENTS AND COMPOSITIONS
CN104761637B (en) 2006-03-31 2021-10-15 中外制药株式会社 Method for regulating antibody hemodynamics
EP3127921A1 (en) 2007-09-26 2017-02-08 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substition in cdr
TWI564021B (en) 2008-04-11 2017-01-01 Chugai Pharmaceutical Co Ltd Repeated binding of antigen to antigen binding molecules
TWI761912B (en) 2010-11-30 2022-04-21 日商中外製藥股份有限公司 Antibody having calcium-dependent antigen-binding ability
MX352889B (en) 2011-02-25 2017-12-13 Chugai Pharmaceutical Co Ltd Fcî“riib-specific fc antibody.
EP2518157A1 (en) 2011-04-26 2012-10-31 Sanofi Test Systems and methods for identifying a compound altering cellular DDR activity
US9550835B2 (en) 2011-08-23 2017-01-24 Chugai Seiyaku Kabushiki Kaisha Anti-DDR1 antibody having anti-tumor activity
TW201817745A (en) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
WO2013047748A1 (en) 2011-09-30 2013-04-04 中外製薬株式会社 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
CN104080909A (en) 2011-11-30 2014-10-01 中外制药株式会社 Drug containing carrier into cell for forming immune complex
CN113831406A (en) 2012-08-24 2021-12-24 中外制药株式会社 Fc gamma RIIb specific Fc region variants
CA2908350C (en) 2013-04-02 2023-08-08 Futa Mimoto Fc region variant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900529A (en) * 1989-03-03 1990-10-01 Eurodiagnostics B V METHOD AND KIT FOR DETERMINING TYROSINE PHOSPHORYLATING AND DEPHOSPHORLING ACTIVITY.
CA2062377A1 (en) * 1991-03-21 1992-09-22 Mariano Barbacid Method for detection of neuroactive substances

Also Published As

Publication number Publication date
WO1995002187A1 (en) 1995-01-19
ZA944983B (en) 1996-01-08
AU7081094A (en) 1995-02-06

Similar Documents

Publication Publication Date Title
GB9125623D0 (en) Cell modification
ZA935284B (en) Photovoltaic cell
IL125126A0 (en) Electroconversion cell
TW441662U (en) Cell material structure
EP0534416A3 (en) Solar cell
GB9314271D0 (en) Cell growth factor receptors
EP0534473A3 (en) Solar cell
EP0537730A3 (en) Solar cell
AU4410893A (en) Electrolytic cell
GB9311252D0 (en) Cell growth regualtors
ZA914783B (en) Mast cell growth factor
GB9206732D0 (en) Photovoltaic cells
SG52238A1 (en) Haemopoietic growth factor antagonists
IL102374A0 (en) Nanocrystalline cell
IL96902A0 (en) T cell growth factor
GB9225928D0 (en) Growth factor
GB9424232D0 (en) Growth factor expression
GB9107612D0 (en) Cell culture
GB9309833D0 (en) Artificial flower arrangement
EP0891372A4 (en) Growth factor htter36
GB9425050D0 (en) Cell line
GB9225776D0 (en) Cell line
GB9213256D0 (en) Cell
GB9318528D0 (en) Cell line
GB9306945D0 (en) Cell modification